Physician profile
Anna Mellor
NPI 1316998776
$1,768.02
in general payments reported to CMS, 2019-2025
26 companies · $16.67 in 2025
The $16.67 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $565 · 2020: $242 · 2021: $290 · 2022: $313 · 2023: $341 · 2025: $16.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $229.09 | 2019-2021 | |
| Lilly USA, LLC | $190.41 | 2019-2023 | Jardiance |
| Abbvie INC. | $173.80 | 2019-2025 | |
| Amarin Pharma, INC. | $168.12 | 2019-2021 | |
| Novo Nordisk INC | $160.60 | 2019-2023 | Ozempic, Rybelsus |
| Astellas Pharma US INC | $128.11 | 2020-2023 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.97 | 2019-2023 | Jardiance |
| Dexcom, INC. | $121.37 | 2022 | |
| Glaxosmithkline, LLC. | $86.41 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.48 | 2021-2022 | |
| Pfizer INC. | $57.12 | 2019-2020 | |
| Sanofi Pasteur INC. | $29.10 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $23.99 | 2019 | |
| Radius Health, INC. | $22.64 | 2019 | |
| Therapeuticsmd, INC. | $21.43 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $20.68 | 2020 | |
| Bausch Health US, LLC | $19.47 | 2020 | |
| Merck Sharp & Dohme LLC | $16.83 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $16.30 | 2019 | |
| Irhythm Technologies, INC. | $15.95 | 2023 | Zio Xt Patch |
| Biohaven Pharmaceuticals, INC. | $15.49 | 2021 | |
| Arbor Pharmaceuticals, INC. | $15.46 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.29 | 2021 | |
| Electromed, INC. | $13.22 | 2021 | |
| Ibsa Pharma INC. | $12.96 | 2019 | |
| Genentech USA, INC. | $12.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Mellor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.